ARTICLE
This journal isMagnetic nanoparticles have shown an increasing number of applications in the field of molecular medicine. In the present study we investigated the controlled synthesis of biocompatible polymer coated iron oxide nanoparticles (Fe2O3) loaded with baicalein and evaluation for their drug loading, releasing behaviour. Moreover, loaded particles were evaluated for its antiproliferation, cell cycle arrest and apoptosis activating properties in triple negative breast cancer cells. The structure, morphology and the magnetic properties of the prepared materials were studied by using scanning electronic microscopy, transmission electronic microscopy, Fourier transform infrared spectroscopy, X-ray diffraction analysis, Thermogravimetric analysis, Dynamic light scattering analysis and zeta potential analyzer. DLS and TEM analysis confirmed that the size of synthesized iron oxide nanoparticles are about 90-100nm and extremely crystalline, spherical in nature. FTIR analysis confirmed that the baicalein molecules were conjugated with PEG coated iron oxide nanoparticles. X-ray diffraction pattern indicated that the magnetic nanoparticles were highly pure with a spinel structure. Baicalein loaded nanoparticles showed a controlled release profile in response to various pH levels. We found that significant cell cycle arrest at various phases in the treated group and subsequent apoptotic cell death was evidenced with AO/EtBr, DAPI and PI of fluorescence microscopic analysis. TUNEL assay evidenced that DNA damage occurred in the treated cells. Further baicalein loaded iron oxide nanoparticles exhibits significant down-regulation of anti-apoptotic protein Bcl-2 and up-regulation of pro-apoptotic proteins evidenced with western blot. Our findings have clearly demonstrated that baicalein loaded iron oxide nanoparticles could efficiently deliver the drug of interest, initiate and execute the apoptotic process in triple negative breast cancer cells. This could pave a new window on polymer surface chemistry to develop metal oxide based drug delivery system for all kinds of cancer therapeutics.